Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism-Reference-Cited by-同舟云学术

Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism

Published:2019-08-19 Issue:11 Volume:94 Page:1185-1192
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Wysokinski Waldemar E.¹^ORCID,Houghton Damon E.¹,Casanegra Ana I.¹,Vlazny Danielle T.¹,Bott‐Kitslaar Dalene M.¹,Froehling David A.¹,Hodge David O.²,Peterson Lisa G.¹,Mcbane Robert D.¹

Affiliation:

1. Vascular Medicine DivisionGonda Vascular Center, Mayo Clinic Rochester Minnesota

2. Department of Health Sciences ResearchMayo Clinic Jacksonville Florida

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25604

Reference21 articles.

1. Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis

2. Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey

3. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study

4. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

5. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating cancer-associated venous thromboembolism: A practical approach;European Journal of Cancer;2024-09

2. Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study;Journal of Thrombosis and Thrombolysis;2024-05-12

3. Structured benefit–risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer;Pharmacoepidemiology and Drug Safety;2024-04-29

4. Echocardiographic findings in cancer-associated non-bacterial thrombotic endocarditis: clinical series of 111 patients from a single institution;European Heart Journal - Cardiovascular Imaging;2024-04-25

5. Cancer‐associated non‐bacterial thrombotic endocarditis—Clinical series from a single institution;American Journal of Hematology;2024-02-13